Mark T. Muller

4.7k total citations
88 papers, 3.8k citations indexed

About

Mark T. Muller is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Mark T. Muller has authored 88 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 16 papers in Epidemiology and 15 papers in Oncology. Recurrent topics in Mark T. Muller's work include Cancer therapeutics and mechanisms (39 papers), DNA and Nucleic Acid Chemistry (24 papers) and DNA Repair Mechanisms (18 papers). Mark T. Muller is often cited by papers focused on Cancer therapeutics and mechanisms (39 papers), DNA and Nucleic Acid Chemistry (24 papers) and DNA Repair Mechanisms (18 papers). Mark T. Muller collaborates with scholars based in United States, South Korea and Italy. Mark T. Muller's co-authors include Jeffrey R. Spitzner, Douglas K. Trask, In Kwon Chung, Veela B. Mehta, Deepa Subramanian, Joseph A. DiDonato, William P. Pfund, Bongyong Lee, Mi Ran Kang and J. B. Hudson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Mark T. Muller

86 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark T. Muller United States 38 2.8k 802 435 387 358 88 3.8k
Chiang J. Li United States 21 1.7k 0.6× 712 0.9× 230 0.5× 204 0.5× 322 0.9× 42 2.8k
Daniel Meruelo United States 35 1.6k 0.6× 414 0.5× 339 0.8× 944 2.4× 192 0.5× 128 3.7k
Tao‐shih Hsieh United States 33 2.9k 1.0× 549 0.7× 48 0.1× 257 0.7× 230 0.6× 68 3.1k
Kazunori Hanada Japan 26 1.8k 0.6× 683 0.9× 184 0.4× 175 0.5× 405 1.1× 71 3.4k
John J. Siekierka United States 35 3.5k 1.2× 1.1k 1.4× 266 0.6× 290 0.7× 528 1.5× 76 5.1k
Martin Renatus United States 26 3.5k 1.2× 720 0.9× 628 1.4× 367 0.9× 146 0.4× 39 4.6k
Erinna F. Lee Australia 37 4.4k 1.5× 1.1k 1.4× 616 1.4× 154 0.4× 406 1.1× 73 5.5k
Mary E. McGrath United States 25 1.6k 0.5× 337 0.4× 284 0.7× 571 1.5× 316 0.9× 37 2.7k
Katerina V. Gurova United States 34 2.3k 0.8× 823 1.0× 205 0.5× 137 0.4× 154 0.4× 84 3.1k
M. Renko Slovenia 21 1.4k 0.5× 355 0.4× 133 0.3× 141 0.4× 218 0.6× 37 2.5k

Countries citing papers authored by Mark T. Muller

Since Specialization
Citations

This map shows the geographic impact of Mark T. Muller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Muller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Muller more than expected).

Fields of papers citing papers by Mark T. Muller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Muller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Muller. The network helps show where Mark T. Muller may publish in the future.

Co-authorship network of co-authors of Mark T. Muller

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Muller. A scholar is included among the top collaborators of Mark T. Muller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Muller. Mark T. Muller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allen, Brittany N., Augusto Schneider, Berta Victoria, et al.. (2018). Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells. Frontiers in Oncology. 8. 217–217. 14 indexed citations
2.
Pezone, Antonio, Alfonso Tramontano, Ermanno Florio, et al.. (2017). High-coverage methylation data of a gene model before and after DNA damage and homologous repair. Scientific Data. 4(1). 170043–170043. 10 indexed citations
3.
Méndez‐Lucio, Oscar, et al.. (2014). Toward Drug Repurposing in Epigenetics: Olsalazine as a Hypomethylating Compound Active in a Cellular Context. ChemMedChem. 9(3). 560–565. 56 indexed citations
4.
Morano, Alessandra, Tiziana Angrisano, Giandomenico Russo, et al.. (2013). Targeted DNA methylation by homology-directed repair in mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids Research. 42(2). 804–821. 52 indexed citations
5.
Merolla, Francesco, Chiara Luise, Mark T. Muller, et al.. (2012). Loss of CCDC6, the First Identified RET Partner Gene, Affects pH2AX S139 Levels and Accelerates Mitotic Entry upon DNA Damage. PLoS ONE. 7(5). e36177–e36177. 32 indexed citations
6.
Kim, Jun Hyun, Sun-Mi Park, Mi Ran Kang, et al.. (2005). Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT. Genes & Development. 19(7). 776–781. 154 indexed citations
7.
Lee, Gun Eui, et al.. (2004). DNA-Protein Kinase Catalytic Subunit-interacting Protein KIP Binds Telomerase by Interacting with Human Telomerase Reverse Transcriptase. Journal of Biological Chemistry. 279(33). 34750–34755. 40 indexed citations
8.
Kang, Mi Ran, Mark T. Muller, & In Kwon Chung. (2004). Telomeric DNA Damage by Topoisomerase I. Journal of Biological Chemistry. 279(13). 12535–12541. 25 indexed citations
9.
Subramanian, Deepa, et al.. (2003). ICE Bioassay: Isolating In Vivo Complexes of Enzyme to DNA. Humana Press eBooks. 95. 137–148. 60 indexed citations
10.
Muller, Mark T., et al.. (2001). Downregulation of topoisomerase I in differentiating human intestinal epithelial cells. International Journal of Cancer. 94(2). 200–207. 11 indexed citations
11.
Choi, In Young, Mi Ran Kang, Soung Soo Kim, et al.. (1998). DNA topoisomerase II cleavage of telomeres in vitro and in vivo. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1395(1). 110–120. 31 indexed citations
12.
Ferguson, Anne, Paula M. Vertino, Jeffrey R. Spitzner, et al.. (1997). Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2′deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells. Journal of Biological Chemistry. 272(51). 32260–32266. 132 indexed citations
13.
14.
Spitzner, Jeffrey R., In Kwon Chung, & Mark T. Muller. (1995). Determination of 5′ and 3′ DNA Triplex Interference Boundaries Reveals the Core DNA Binding Sequence for Topoisomerase II. Journal of Biological Chemistry. 270(11). 5932–5943. 15 indexed citations
15.
Chung, In Kwon, Veela B. Mehta, Jeffrey R. Spitzner, & Mark T. Muller. (1992). Eukaryotic topoisomerase II cleavage of parallel stranded DNA tetraplexes. Nucleic Acids Research. 20(8). 1973–1977. 36 indexed citations
16.
DiDonato, Joseph A., Jeffrey R. Spitzner, & Mark T. Muller. (1991). A predictive model for DNA recognition by the herpes simplex virus protein ICP4. Journal of Molecular Biology. 219(3). 451–470. 41 indexed citations
17.
Spitzner, Jeffrey R., In Kwon Chung, & Mark T. Muller. (1990). Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucleic Acids Research. 18(1). 1–11. 155 indexed citations
18.
Muller, Mark T., et al.. (1989). A rapid and quantitave microtiter assay for eukaryotic topisomerase II. Nucleic Acids Research. 17(22). 9499–9499. 27 indexed citations
19.
Spitzner, Jeffrey R. & Mark T. Muller. (1988). A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Research. 16(12). 5533–5556. 230 indexed citations
20.
Le, Phong T., Mark T. Muller, & Richard F. Mortensen. (1982). Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine.. The Journal of Immunology. 129(2). 665–672. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiang J. Li Breakdown of academic impact, for papers by Daniel Meruelo Breakdown of academic impact, for papers by Tao‐shih Hsieh Breakdown of academic impact, for papers by Kazunori Hanada Breakdown of academic impact, for papers by John J. Siekierka Breakdown of academic impact, for papers by Martin Renatus Breakdown of academic impact, for papers by Erinna F. Lee Breakdown of academic impact, for papers by Mary E. McGrath Breakdown of academic impact, for papers by Katerina V. Gurova Breakdown of academic impact, for papers by M. Renko
Rankless by CCL
2026